An ingestible sensor that allows doctors to remotely monitor tuberculosis patients' intake of medication has the potential to save millions of lives and revolutionise treatment for the world's most deadly infectious disease, researchers said Friday.
Around 10 million people contract tuberculosis annually, and in 2017 1.6 million people died from the chronic lung disorder.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: